Table 1.
Summary of clinical features of the injury archetype groups.
| AKI1 | AKI2 | Minor injury | CKD/AKI | CKD | No injury | ||
|---|---|---|---|---|---|---|---|
| N | 127 | 130 | 377 | 55 | 310 | 527 | |
| Clinical variables for all biopsies | Median time of biopsy post-transplant (mean) | 40 (181) | 51 (157) | 1,070 (1,875) | 867 (1,670) | 2,102 (2,674) | 365 (1,088) |
| Mean eGFR (cc/min/m2) | 22 | 27 | 52 | 32 | 35 | 53 | |
| Mean donor age (median) | 50 (54) | 46 (48) | 41 (42) | 46 (48) | 45 (46) | 43 (44) | |
| % of column with donor age >50 years | 63% | 43% | 32% | 45% | 41% | 33% | |
| Deceased donor (%) | 89% a | 65% | 67% | 73% | 73% | 60% | |
| Clinical variables for biopsies with no molecular rejection | Median time of biopsy post-transplant (mean) | 32 (177) | 19 (81) | 1,050 (1,929) | 1,221 (1,412) | 2,510 (2,890) | 309 (1,089) |
| Mean eGFR (cc/min/m2) | 21 | 26 | 54 | 48 | 35 | 52 | |
| Mean donor age (median) | 50 (54) | 50 (52) | 43 (43) | 44 (40) | 47 (50) | 44 (45) | |
| % of column with donor age >50 years | 62% | 59% | 33% | 40% | 51% | 36% | |
| Deceased donor (%) | 89%b | 74% | 70% | 100% | 75% | 59% |
The highest in each row is bolded and shaded. The lowest in each row is bolded and italicized.
a
Fisher's exact test between AKI1 vs. AKI2 p < 0.001.
b
Fisher's exact test between AKI1 vs. AKI2 p = 0.02.